AKT1 and cancer: Dysregulation of the PI3K/AKT signaling pathway, known to be associated with a number of human cancers, results in aberrant activation of numerous protein targets regulating a wide range of cellular processes critical for proliferation, tumorigenesis, survival, and growth [12,14].